Global Alliance to Share Genomic Data

Leading medical and research centers around the world announce a plan to share massive amounts of genetic and clinical information.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, ALENGOMore than 70 medical and research centers around the world have agreed to create an organized system to share vast amounts of genetic and clinical information, according to The New York Times. This “global alliance” released a white paper last week (June 3) announcing plans to thrash out standards on ethical and technical issues, such as patient privacy and data format, and to pave the way for a massive database that would be open to doctors and researchers everywhere.

“No single hospital, research group or even country alone is going to be able to collect all the data that will be needed to inform medicine and science,” David Altschuler, deputy director of the Broad Institute at Harvard and Massachusetts Institute of Technology, who was part of the organizing committee behind the document, told The Guardian. “But if we're able to look across datasets, we'll have greater progress, and we'll be able to offer people better information.”

The plummeting cost of DNA sequencing over the past few years has resulted in an avalanche of genomic data. But to fully understand the relationships between mutations and disease, researchers have to compare genetic and clinical data from hundreds of thousands of patients and healthy individuals. That’s not ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies